This company seems to have been delisted
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Reason: Acquired by Mars, Incorporated
Last recorded trade on: August 15, 2023
Source: https://www.mars.com/news-and-stories/press-releases-statements/mars-to-acquire-heska-global-provider-advanced-veterinary-solutions
Heska Corporation
HSKA
NZ$196.66
Share price
0.00%
Change (1 day)
29.40%
Change (1 year)
Categories
Heska Corporation (HSKA) - Total liabilities
Total liabilities on the balance sheet as of March 2023 : NZ$0.28 Billion
According to Heska Corporation 's latest financial reports the company's total liabilities are NZ$0.28 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Heska Corporation - Total liabilities on balance sheet (from 2001 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | NZ$0.25 B | 4.63% |
| 2021-12-31 | NZ$0.24 B | 57.55% |
| 2020-12-31 | NZ$0.15 B | 16.89% |
| 2019-12-31 | NZ$0.13 B | 163.48% |
| 2018-12-31 | NZ$50.75 M | 1.97% |
| 2017-12-31 | NZ$49.77 M | -21.41% |
| 2016-12-31 | NZ$63.33 M | -6.16% |
| 2015-12-31 | NZ$67.48 M | 20.97% |
| 2014-12-31 | NZ$55.78 M | -1.27% |
| 2013-12-31 | NZ$56.5 M | 158.78% |
| 2012-12-31 | NZ$21.83 M | 26.67% |
| 2011-12-31 | NZ$17.23 M | -22.9% |
| 2010-12-31 | NZ$22.35 M | -14.88% |
| 2009-12-31 | NZ$26.26 M | -45.39% |
| 2008-12-31 | NZ$48.1 M | 12.65% |
| 2007-12-31 | NZ$42.7 M | -5.24% |
| 2006-12-31 | NZ$45.06 M | -8.2% |
| 2005-12-31 | NZ$49.08 M | -3.1% |
| 2004-12-31 | NZ$50.65 M | 2.13% |
| 2003-12-31 | NZ$49.59 M | -1.59% |
| 2002-12-31 | NZ$50.39 M | 1.63% |
| 2001-12-31 | NZ$49.58 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 IDEXX Laboratories IDXX | NZ$2.89 B | 908.71% | 🇺🇸 USA |
 Eli Lilly LLY | NZ$120.53 B | 41,913.44% | 🇺🇸 USA |
 Petco WOOF | NZ$6.57 B | 2,193.03% | 🇺🇸 USA |
 Pfizer PFE | NZ$192.40 B | 66,963.71% | 🇺🇸 USA |
 Merck MRK | NZ$109.35 B | 38,017.27% | 🇺🇸 USA |
 Novartis NVS | NZ$100.78 B | 35,027.74% | 🇨🇭 Switzerland |
 Zoetis ZTS | NZ$15.47 B | 5,294.64% | 🇺🇸 USA |